NDC 83301-0003-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0003
- Requested NDC
- 83301-0003-01
- Package NDCs from labels
- 83301-0003-1, 83301-0003-2, 83301-0003-3, 83301-0003-01
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd
- Effective date
- 2025-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | 2025-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0003-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 10 | |
| 83301-0003-2 | Gabapentin | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | 10 | |
| 83301-0003-3 | Gabapentin | 1000 in 1 BOTTLE, PLASTIC | CAPSULE | 1000 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0003 | GABAPENTIN CAPSULE [MULLAN PHARMACEUTICAL INC.] | 9 | Current NDC, 3 package rows | 20250411_74474aa4-4859-42d2-92d8-f23f18b34e04.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0003-1 | EA - Each | 83301-0003 | 48fb29f0-710e-4631-a0ae-f2d137c5ce80 | 1 | 2025-07-08 |
| 83301-0003-2 | EA - Each | 83301-0003 | 36eeae7f-ed52-4f55-a41b-deb411872750 | 1 | 2025-07-08 |
| 83301-0003-3 | EA - Each | 83301-0003 | 5fdaad8f-bb94-40a7-a1e6-0ca5cb6b74da | 1 | 2024-10-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 20e48004-d8b6-40fd-929b-b95087b4d85d | 2022-11-28 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c7cb37f9-e1df-4e2a-bde5-9bfa0e040d7a | 2022-11-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 88ac51c4-5fa9-4c35-9c63-f26bcb101d4b | 2022-10-18 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8 | 2022-10-12 | Warnings, Adverse reactions | 310430 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9d544944-ea95-42e1-8c65-9e442437f0ee | 2022-10-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f651a143-3f88-49c9-b5c4-c9af55aea76a | 2022-10-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 176c5b60-93c2-4574-8b51-c15180912aaa | 2022-08-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Neurontin | GABAPENTIN | Parke-Davis Div of Pfizer Inc | ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388 | 2022-07-12 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 14b1840d-a2db-4eec-bc25-029e35b042e4 | 2022-07-09 | Warnings, Adverse reactions | 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | c18d9d06-f796-4eb7-8fd5-1de4ebb95439 | 2022-07-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Addiclenz | BETA VULGARIS, BOLDO, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYL PARABEN, PROPYL PARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Deseret Biologicals, Inc. | e39235ea-2a2f-44a7-92d6-fb1d428ebabd | 2022-05-12 | Warnings | 15FIX9V2JP |
| GABAPENTIN | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 17988b64-723c-488d-befd-3e4e4cc44bd2 | 2022-05-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | ed22b78e-93ff-4cb5-9c9c-2afe9b60dd2e | 2022-05-02 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 645824d0-eb3d-442b-806d-36a70796cb8e | 2022-05-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | aa3ab216-372a-4a72-bfd1-88a1ffa31ba3 | 2022-05-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | b67b7865-df64-429a-9550-5333b9c713ea | 2022-04-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 223a9216-6e07-49b9-8faf-bb4e529a6ae5 | 2022-04-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2fb2233f-9152-4630-ab39-51a0cda7e5ca | 2022-04-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 52af51ab-6543-466b-848c-13c588c98789 | 2022-04-01 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2b76955c-52a4-4026-b286-3da1112fe989 | 2022-04-01 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.